Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 U.S. intrauterine devices industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Age group trends
2.1.4 Zonal trends
Chapter 3 US Intrauterine Devices Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Favorable regulatory scenario
3.2.1.2 Rising awareness among U.S. women regarding various IUD applications
3.2.1.3 High number of unintended pregnancies
3.2.1.4 Government initiatives for the prevention of unwanted abortions and pregnancies
3.2.1.5 Growing inclination towards planned delayed pregnancy
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of device
3.2.2.2 Risk of several health issues
3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By age group
3.4 COVID- 19 impact analysis
3.5 U.S. intrauterine device units sold, by brand, 2018 - 2030
3.6 Number of insertions/procedures, 2018 – 2032 (Number of procedures)
3.7 Regulatory landscape
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Technology landscape
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive Positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 US Intrauterine Devices Market, By Product
5.1 Key product trends
5.2 Copper IUD
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Hormonal IUD
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 US Intrauterine Devices Market, By Age Group
6.1 Key age group trends
6.2 15-19
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 20-24
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 25-29
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 30-34
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 35-39
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 40-44
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 45+
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 US Intrauterine Devices Market, By Zone
7.1 Key zonal trends
7.2 East North Central
7.2.1 Illinois
7.2.2 Indiana
7.2.3 Michigan
7.2.4 Ohio
7.2.5 Wisconsin
7.3 West South Central
7.3.1 Arkansas
7.3.2 Louisiana
7.3.3 Oklahoma
7.3.4 Texas
7.4 South Atlantic
7.4.1 Delaware
7.4.2 Florida
7.4.3 Georgia
7.4.4 Maryland
7.4.5 North Carolina
7.4.6 South Carolina
7.4.7 Virginia
7.4.8 West Virginia
7.4.9 Washington, D.C.
7.5 North East
7.5.1 Connecticut
7.5.2 Maine
7.5.3 Massachusetts
7.5.4 New Hampshire
7.5.5 Rhode Island
7.5.6 Vermont
7.5.7 New Jersey
7.5.8 New York
7.5.9 Pennsylvania
7.6 East South Central
7.6.1 Alabama
7.6.2 Kentucky
7.6.3 Mississippi
7.6.4 Tennessee
7.7 West North Central
7.7.1 Iowa
7.7.2 Kansas
7.7.3 Minnesota
7.7.4 Missouri
7.7.5 Nebraska
7.7.6 North Dakota
7.7.7 South Dakota
7.8 Pacific Central
7.8.1 Alaska
7.8.2 California
7.8.3 Hawaii
7.8.4 Oregon
7.8.5 Washington
7.9 Mountain States
7.9.1 Arizona
7.9.2 Colorado
7.9.3 Utah
7.9.4 Nevada
7.9.5 New Mexico
7.9.6 Idaho
7.9.7 Montana
7.9.8 Wyoming
Chapter 8 Company Profiles
8.1 Bayer AG
8.2 CooperSurgical Inc. (CooperCompanies)
8.3 Allergan (AbbVie, Inc.)
8.4 Mylan N.V. (Viatris)
